NewsGlaxoSmithKline Pharmaceuticals Uploads Analyst Meeting Recording in Compliance with SEBI RegulationsGlaxoSmithKline Pharmaceuticals Uploads Analyst Meeting Recording in Compliance with SEBI Regulations
GlaxoSmithKline Pharmaceuticals Limited has uploaded analyst and institutional investor meeting recordings on its website in compliance with SEBI regulations. The recording is available on the company's investor portal, fulfilling disclosure requirements under Regulation 30 of SEBI LODR Regulations 2015.
*this image is generated using AI for illustrative purposes only.
GlaxoSmithKline Pharmaceuticals Limited has notified the stock exchanges regarding the upload of analyst and institutional investor meeting recordings on its official website. The company has communicated this development to both BSE Limited and the National Stock Exchange of India Limited through an official letter dated 6th November 2025.
Regulatory Compliance
The pharmaceutical company has fulfilled its disclosure obligations pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions.
Recording Availability
The audio recording of the analyst and institutional investor meetings has been uploaded to the company's dedicated investor portal. Stakeholders can access the recording through the company's official website at india-pharma.gsk.com under the investors section.
| Parameter: | Details |
|---|---|
| Upload Date: | 6th November 2025 |
| Regulatory Framework: | SEBI LODR Regulation 30 |
| Access Portal: | india-pharma.gsk.com/en-in/investors/analyst-meets/ |
| Document Signatory: | Ajay Nadkarni, Vice President & Company Secretary |
Corporate Information
The notification was signed by Ajay Nadkarni, who serves as Vice President – Administration, Real Estate & Company Secretary for GlaxoSmithKline Pharmaceuticals Limited. The company is headquartered at GSK House, Dr. Annie Besant Road, Worli, Mumbai, and operates under CIN: L24239MH1924PLC001151.
This disclosure ensures transparency and provides investors with access to important corporate communications and strategic discussions held during the analyst meetings.
Historical Stock Returns for GlaxoSmithKline Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.10% | -7.84% | -10.24% | +5.17% | -7.69% | +71.88% |
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
